Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Hepu Biotechnology is a high-tech medical enterprise specializing in the development and industrialization of clinical mass spectrometry (MS) systems and diagnostic solutions. Headquartered in Ningbo, China, the company provides an integrated platform that includes high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) hardware, automated sample processing equipment, and specialized reagent kits. Their product portfolio focuses on high-demand clinical applications such as therapeutic drug monitoring (TDM), vitamin testing, and metabolic screening. By offering localized, high-precision diagnostic tools, Hepu Biotech aims to enhance the accessibility of precision medicine and clinical proteomics in hospitals and laboratories. The company's flagship products, such as the HP-MS 1000, are designed to streamline clinical workflows and improve the accuracy of complex biochemical analyses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Hepu Biotechnology.